** Shares of Australia's Firebrick Pharma FRE.AX rise as much as 11.1% to A$0.100, their highest level since April 17, 2024
** Stock on track to record its second straight day of gains, if trend holds
** Pharmaceutical co gets A$1.1 mln ($684,090.00) strategic investment from Pharma Nutria N.A. (PNAI), an entity associated with Firebrick's licensing partner in the Philippines
** Adds PNAI is acquiring 11.6 million shares in Firebrick at an issue price of A$0.095 per share, which represents a 5.6% premium to FRE's last closing
** New funds will be used to support marketing costs of Nasodine Nasal Spray in Singapore - FRE
** Stock has risen 59.7% this year so far
($1 = 1.6080 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.